Home > Compound List > Compound details
162254297 molecular structure
click picture or here to close

[(3S)-3-amino-3-[(3-hexylphenyl)carbamoyl]propyl]phosphonic acid hydrobromide

ChemBase ID: 160162
Molecular Formular: C16H28BrN2O4P
Molecular Mass: 423.282281
Monoisotopic Mass: 422.09700602
SMILES and InChIs

SMILES:
c1(cccc(c1)CCCCCC)NC(=O)[C@H](CCP(=O)(O)O)N.Br
Canonical SMILES:
CCCCCCc1cccc(c1)NC(=O)[C@H](CCP(=O)(O)O)N.Br
InChI:
InChI=1S/C16H27N2O4P.BrH/c1-2-3-4-5-7-13-8-6-9-14(12-13)18-16(19)15(17)10-11-23(20,21)22;/h6,8-9,12,15H,2-5,7,10-11,17H2,1H3,(H,18,19)(H2,20,21,22);1H/t15-;/m0./s1
InChIKey:
PIGJYNCMLIOKSN-RSAXXLAASA-N

Cite this record

CBID:160162 http://www.chembase.cn/molecule-160162.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
[(3S)-3-amino-3-[(3-hexylphenyl)carbamoyl]propyl]phosphonic acid hydrobromide
IUPAC Traditional name
(3S)-3-amino-3-[(3-hexylphenyl)carbamoyl]propylphosphonic acid hydrobromide
Synonyms
(S)-W-146 Hydrobromide
[(3S)-3-Amino-4-[(3-hexylphenyl)amino]-4-oxobutyl]phosphonic Acid Hydrobromide
PubChem SID
162254297
PubChem CID
71313261

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID
TRC A611070 external link Add to cart
PubChem 71313261 external link
Data Source Data ID Price
TRC
A611070 external link Add to cart Please log in.
Data Source Data ID
PubChem 71313261 external link

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem
Acid pKa 1.7897012  H Acceptors
H Donor LogD (pH = 5.5) 0.76330346 
LogD (pH = 7.4) 0.66015303  Log P 0.7640849 
Molar Refractivity 92.2704 cm3 Polarizability 35.580723 Å3
Polar Surface Area 112.65 Å2 Rotatable Bonds 10 
Lipinski's Rule of Five true 

PROPERTIES

PROPERTIES

Safety Information Product Information Bioassay(PubChem)
MSDS Link
Download expand Show data source
Certificate of Analysis
Download expand Show data source

DETAILS

DETAILS

TRC TRC
Toronto Research Chemicals - A611070 external link
Sphingosine-1-phosphate, analogs and antagonists for use as medicaments for treating and/or preventing cardiovascular conditions in patients with Fabry disease.

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • • Dudek, S., et al.: J. Biol. Chem., 279, 24692 (2004)
  • • Alfonso, C., et al.: Eur. J. Immunol., 36, 149 (2004)
  • • Balatoni, B., et al.: Brain Res. Bull., 74, 307 (2004)
  • • Cherezov, V., et al.: Science, 318, 1258 (2004)
  • • Foss, F., et al.: Bioorg. Med. Chem., 15,
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle